FDA extends interim deal but issues dog CryoLife
This article was originally published in Clinica
Executive Summary
Things do not seem to be getting any worse for CryoLife, but they are not getting better very quickly either. The Atlanta, Georgia firm is still striving to shake free of the contamination issues that had such a negative effect on it for much of last year. Meanwhile, it faces ongoing compliance problems with its reporting procedures for adverse reactions.